How AI, automation, and machine learning are upgrading clinical trials
Artificial intelligence (AI) is set to be the most disruptive emerging technology in drug development in 2023, unlocking advanced analytics,…
All articles by Annaliese Watkins
Annaliese Watkins
-
-
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
-
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
-
Regulatory requirements for clinical trials: A comparison of Australia and the US
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…